Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
ConclusionsThis report suggests that systemic immunotherapy with or without topical interferon is effective in treatment of malignant melanoma of the conjunctiva. Therefore, it can be considered for patients with advanced local conjunctival melanoma, those who refuse orbital exenteration surgery and those with systemic metastasis.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Cancer | Cancer & Oncology | Cervical Cancer | Cervical Discectomy | Chemotherapy | Dermatitis | Dermatology | Eyes | Immunotherapy | Melanoma | Opthalmology | PET Scan | Radiation Therapy | Skin Cancer | Toxicology | Yervoy